ASAM released a draft for prescription guidelines: Here's what we did in response

Since 2022, the American Society of Addiction Medicine (ASAM) has been working on producing a set of recommendations to guide practitioners in the often-difficult task of helping benzodiazepine-dependent patients discontinue this medication. This guideline will set the standard for clinical practice for discontinuation of benzodiazepines for at least the next decade. It will determine how patients are treated. It is therefore imperative that the guideline accurately represent the best evidence-based practice for deprescribing benzodiazepines.
This video explains what the Alliance is doing in response to the release of the ASAM draft guidelines #BenzoReform
#Benzodiazepines #BenzoAwareness #Benzos #BenzoWithdrawal #BenzoRecovery #BenzoTapering #BenzoSafety #BenzodiazepineWithdrawal #TaperingSupport #BenzoCrisis #informedconsent #MentalHealthMatters #MentalHealthAwareness #RecoveryJourney #MentalHealthSupport #TraumaRecovery #SupportRecovery #EndTheStigma #WellnessJourney #MindfulRecovery #HealthAndWellness

[@cxvzf]

Thanks for posting. These medications are both life saving and a potential harm. It’s important we have the education to reduce harm. In my non clinical opinion, I just hope the outcome isn’t patients being tapered off when it may benefit them.

[@michaels.2331]

Do you know anything about catatonia and Ativan?